Products

Albert Invent's Electronic Lab Notebook (ELN) is a comprehensive digital solution designed to streamline chemistry workflows by integrating essential laboratory functions into a single, user-friendly platform. It offers chemists an intuitive interface to document experiments, manage data, and collaborate effectively, enhancing productivity and innovation in research and development.

Tierra Biosciences is a synthetic biology company that accelerates the pace of discovery and enables the next generation of bio-based materials. Their platform combines high-throughput protein manufacturing with the simplicity of e-commerce, making custom protein production as easy as ordering synthetic DNA. By lowering the traditional barriers to protein synthesis, Tierra serves scientists aiming to innovate with new proteins. Led by a team of protein experts, this rapidly growing company is tr

Sable Bio is a biotechnology company that leverages artificial intelligence to revolutionize drug safety assessments. Their AI-powered platform, Sable Target Intelligence, integrates comprehensive safety data across clinical, genetic, experimental, and literature sources, enabling researchers to systematically evaluate and prioritize toxicology risks. By providing unified and up-to-date safety information, Sable Bio empowers scientists to make faster, more informed decisions, ultimately accelera

Archon Biosciences is a biotechnology company dedicated to advancing healthcare through innovative solutions in molecular diagnostics and personalized medicine. Their primary focus is on developing cutting-edge technologies that enable precise and rapid detection of various diseases, thereby facilitating early intervention and tailored treatment plans.

CellVoyant is an AI-first biotechnology company dedicated to accelerating the development of life-changing therapies aimed at curing chronic diseases. By integrating advanced artificial intelligence with live cell imaging, CellVoyant predicts and optimizes stem cell differentiation processes. This innovative approach enables precise cell analytics and process development, facilitating the scalable and controllable manufacturing of any cell or tissue type within the human body. Operating at the i

Integrated Biosciences is a biotechnology company dedicated to developing next-generation therapeutics targeting aging and age-related diseases. By integrating synthetic biology, chemistry, and machine learning, the company accelerates the discovery of novel small molecules with exceptional precision and speed. Their proprietary platform focuses on cellular stress responses and senescence, addressing traditionally challenging biological targets.

Shift Bioscience is a biotechnology company pioneering the development of artificial intelligence (AI)-driven cell simulation platforms to identify genes capable of safely rejuvenating cells. By integrating generative AI with a highly accurate, high-throughput biological aging clock, Shift Bioscience aims to predict and validate gene sets that can reverse cellular aging without inducing tumorigenic pathways.

Leash Biosciences is a biotechnology company dedicated to revolutionizing drug discovery by integrating machine learning with extensive biochemical data. By screening millions of compounds against thousands of proteins, Leash generates billions of data points, creating a rich dataset ideal for training advanced machine learning models. This approach aims to bridge the existing data gap in medicinal chemistry, facilitating the rapid design of novel small molecule therapeutics.

Differential Bio is pioneering the integration of biology and computation to revolutionize biomanufacturing. Their platform serves as the computational backbone for applying BioAI to regenerative manufacturing, enabling a shift from traditional trial-and-error methods to predictive, digital-first experimentation. This approach accelerates the development of biomanufactured products, making the process faster, more cost-effective, and smarter.

Converge Bio is a pioneering company that integrates Generative AI with biological data to revolutionize drug discovery and development. By leveraging Large Language Models (LLMs) trained on the unique syntax of biological systems, Converge enables biotech and pharmaceutical companies to predict biological outcomes, gain deeper insights, and generate novel molecular candidates. This approach enhances the understanding of complex molecular interactions, signaling pathways, and disease mechanisms,

Nabla Bio is a biotechnology company specializing in the de novo design of antibody therapeutics through the integration of artificial intelligence (AI) and experimental technologies. Founded by experts from George Church's Lab at Harvard, Nabla Bio combines generative AI models with large-scale multiplex experiments to engineer protein-based therapies, particularly targeting applications where traditional discovery methods have been less effective.

Reshape Biotech offers an AI-powered platform that automates the imaging and analysis of petri and microtiter plates, enabling laboratories to capture high-resolution images, extract data instantly, and obtain reliable results.

ZipBio is a biotechnology company founded in 2023, dedicated to revolutionizing therapeutic development through the use of generative AI. Their proprietary COMPACT™ platform compresses complex biological structures into smaller, de novo-designed proteins that retain full functionality. This innovation addresses the size limitations of traditional therapeutics, enhancing delivery and effectiveness for hard-to-treat diseases.

LIMS Digital is a Unified SaaS-based Laboratory Software Suite designed to revolutionize laboratory operations across diverse sectors. Built to meet the complex needs of Medical and Diagnostic Laboratories, Biorepositories, Environmental Labs, and the Cannabis Industry, LIMS Digital delivers scalable, secure, and fully customizable solutions. Whether you're focused on Clinical Diagnostics, managing sample workflows, or ensuring regulatory compliance, LIMS Digital simplifies every stage—from sam

Biolevate is a pioneering company dedicated to integrating ethical artificial intelligence (AI) into the healthcare sector, aiming to create simple, secure, and collaborative solutions that accelerate medical advancements for a more accessible world. By harnessing the power of AI, Biolevate addresses the complex challenges faced by the life sciences industry, offering tailored solutions that enhance efficiency, compliance, and innovation.

PolyModels Hub is a British software startup specializing in SaaS solutions for pharmaceutical process development. Their platform leverages artificial intelligence to assist scientists in modeling, simulating, and gaining insights across all protocols involved in transforming chemical compounds into safe drug products.

Nanite is a pioneering biotechnology company specializing in the development of non-viral gene delivery systems. Their proprietary platform, SAYER™, integrates artificial intelligence with high-throughput experimental and computational methods to design programmable polymer nanoparticles (PNPs). These PNPs are engineered to deliver a wide range of genetic cargoes with tissue specificity, offering a safer and more efficient alternative to traditional viral vectors. By harnessing AI-driven design,

Surge is a pioneering company dedicated to advancing precision medicine by decrypting the human immune system. Founded by experts in immunology and biomedical informatics, Surge integrates cutting-edge technologies to develop innovative solutions that enhance patient care and optimize healthcare outcomes.

Isomorphic Labs is a London-based company founded in 2021, dedicated to revolutionizing drug discovery through the application of artificial intelligence (AI). As a subsidiary of Alphabet Inc., Isomorphic Labs builds upon the groundbreaking AlphaFold system developed by DeepMind, aiming to model complex biological phenomena and design novel molecules to treat and cure various diseases.

Nextmol is a cloud-based computational chemistry platform designed to accelerate the development of new materials and chemicals. By leveraging advanced molecular modeling and simulation techniques, Nextmol enables researchers and scientists to predict the properties and behavior of molecules, facilitating the design of innovative products across various industries.